Streetbeat News

Analyst Ratings

C

VAL

Citigroup analyst Nikhil Gupta maintains a Buy rating on Valaris (NYSE:VAL) and raises the price target from $85 to $113.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:46 pm

PDD

A whale investor has taken a bullish stance on PDD Holdings (NASDAQ:PDD), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $60.0 to $140.0 for PDD Holdings over the last 3 months. The price of PDD is currently down -4.34% at $81.04. The next earnings are expected to be released in 17 days.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 4:45 pm

WRBY

Citigroup analyst Paul Lejuez has maintained a Neutral rating on Warby Parker (NYSE:WRBY) and raised the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:42 pm

C

VOYA

Citigroup analyst Michael Ward maintains a Buy rating on Voya Financial (NYSE:VOYA) and raises the price target from $85 to $86.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:37 pm

ALXO

Piper Sandler analyst Christopher Raymond has maintained an Overweight rating on ALX Oncology Holdings (NASDAQ:ALXO) but lowered the price target from $48 to $8.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:34 pm

OPTN

Piper Sandler analyst David Amsellem has maintained an Overweight rating on OptiNose (NASDAQ:OPTN) but lowered the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:33 pm

RCEL

Piper Sandler analyst Matt O'Brien has maintained an Overweight rating on AVITA Medical (NASDAQ:RCEL) and raised the price target from $18.5 to $23.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:31 pm

DK

Piper Sandler analyst Ryan Todd maintains a Neutral rating on Delek US Holdings (NYSE:DK) and raises the price target from $27 to $29.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:30 pm

BKSY

Benchmark analyst Josh Sullivan maintains a Buy rating on BlackSky Technology (NYSE:BKSY) but has lowered the price target from $4 to $3.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 4:30 pm

APYX

Piper Sandler analyst Matt O'Brien maintains an Overweight rating on Apyx Medical (NASDAQ:APYX) and raises the price target from $4 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 4:29 pm